RETA) DEADLINE: Have you suffered a substantial loss? Contact Johnson Fistel About Reata Class Action | 2022-02-11 | Press Releases
San Diego, Calif.–(Newsfile Corp. – Feb. 11, 2022) – Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has been filed on behalf of investors in Reata Pharmaceuticals, Inc. (“Reata” or the “Company”) (NASDAQ: RETA). The class action is on behalf of shareholders who purchased Reata securities between November 9, 2020 and December 8, 2021, inclusive (the “Class Period”). To serve as lead plaintiff in this class action, you must move the Court no later than February 18, 2022.
What actions can I take at this time? If you have suffered a substantial loss and would like to learn more about the lead plaintiff role, please contact Jim Baker ([email protected]) by email or by phone at 619-814-4471. If emailing, please include a phone number. Additionally, you can:
[Click here to join this action]. There is no cost or obligation for you.
The ReataThe class action alleges that, throughout the Class Period, the defendants made materially false and misleading statements and failed to disclose material adverse facts about the company’s business, operations and prospects. Specifically, the defendants failed to disclose to investors: (1) that the FDA had raised concerns regarding the validity of the clinical study designed to measure the efficacy and safety of bardoxolone for the treatment of kidney disease chronic caused by Alport syndrome; (2) that, therefore, there was a significant risk that Reata’s NDA would not be approved; and (3) that as a result of the foregoing, defendants’ positive statements about the company’s business, operations and prospects were materially misleading and lacked reasonable basis.
A lead plaintiff will act on behalf of all other class members to lead the Reata class action. The lead plaintiff may select a law firm of their choice to litigate the class action. An investor’s ability to share in any potential future recoveries from the Reata class action does not depend on their function as lead plaintiff.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivatives and securities class actions. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Lawyer advertisement. Past results do not guarantee future results.
Johnson Fistel, LLP
Jim Baker, 619-814-4471
[click here to join this action]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/113625